CLAIM CARD
This synthesis maps 44 included sources on Epigenetic clock across 5 outcome classes and 509 cross-study disagreements. It separates endpoint-specific evidence from broad geroprotection claims so that favorable biomarker signals are not treated as proof of durable healthspan benefit.
Evidence grade: exploratory
Contradiction status: none
Publication: 9e9f3163-3f3b-4c1f-9790-a8b1400b8696
Provenance: Derivation Web chain
Citation Support
source_1Bozack 2023source_2McGee 2024source_3Marinello 2025source_4Petersen 2021source_5Arpawong 2023